Cargando…
Correction: Checkpoint inhibitor induced cardiotoxicity: managing the drawbacks of our newest agents against cancer
Autores principales: | Brüstle, Karina, Heidecker, Bettina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161788/ https://www.ncbi.nlm.nih.gov/pubmed/30279972 http://dx.doi.org/10.18632/oncotarget.26113 |
Ejemplares similares
-
Checkpoint inhibitor induced cardiotoxicity: managing the drawbacks of our newest agents against cancer
por: Brüstle, Karina, et al.
Publicado: (2017) -
The Newest of Our Creeds
por: Hodgkin,
Publicado: (1881) -
The Newest of Our Creeds
Publicado: (1878) -
Managing cardiotoxicity associated with immune checkpoint inhibitors
por: Upadhrasta, Sireesha, et al.
Publicado: (2019) -
Cardiotoxicity of immune checkpoint inhibitors
por: Varricchi, Gilda, et al.
Publicado: (2017)